Serological testing for SARS-CoV-2 antibodies

Serological testing for SARS-CoV-2 antibodies

RegulationLaboratory tests, such as serological tests for SARS-CoV-2 antibodies, are regulated by the U.S. Food and Drug Administration (FDA) and also by the Centers for Medicare and Medicaid Services (CMS) under the Clinical Laboratory Improvement Amendments (CLIA). As of May 5, approximately 12 commercial serological tests have been granted EUAs, while over 120 tests are currently on the market. Serological tests for SARS-CoV-2 antibodies present even greater challenges, as much is still unknown about immune status for the novel virus. Some limitations to be aware of include:False positive results : Serological testing for disease with a low prevalence in the population presents inherent challenges with interpretation of positive results. : Serological testing for disease with a low prevalence in the population presents inherent challenges with interpretation of positive results.

About Us

At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.

Subscribe to our newsletter!